These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. Zepp F, Knuf M, Heininger U, Jahn K, Collard A, Habermehl P, Schuerman L, Sänger R. Vaccine; 2004 Jun 02; 22(17-18):2226-33. PubMed ID: 15149781 [Abstract] [Full Text] [Related]
6. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses. Halperin SA, King J, Law B, Mills E, Willems P. Clin Infect Dis; 1999 May 02; 28(5):995-1001. PubMed ID: 10452624 [Abstract] [Full Text] [Related]
9. Clinical trial of concentrated inactivated polio vaccine in a simplified immunization program. Fillastre C, Emmou C, Meyran M, Schlumberger M, Guérin N. Dev Biol Stand; 1981 May 02; 47():207-13. PubMed ID: 6262148 [Abstract] [Full Text] [Related]
10. [20 years' use of the diphtheria-pertussis-tetanus vaccine]. Fillastre C, Guerin N, Ajjan N, Triau R. Pediatrie; 1988 May 02; 43(1):73-9. PubMed ID: 3387184 [Abstract] [Full Text] [Related]
19. [Combined vaccine against tetanus, diphtheria and polio. A randomized controlled study of immunogenicity and tolerance]. Banzhoff A, Donner-Banzhoff N, Schwenke C, Girgsdies OE, Jilg W. Fortschr Med Orig; 2001 Jan 11; 118(4):169-72. PubMed ID: 11217682 [Abstract] [Full Text] [Related]